PALATIN TECHNOLOGIES, INC. Additional Paid in Capital, Common Stock
PALATIN TECHNOLOGIES, INC. (PTN) had Additional Paid in Capital, Common Stock of $5.62 million as of 2023-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2024-11-14
- 2023-09-30: Additional Paid in Capital, Common Stock $5.62M.
- 2023-06-30: Additional Paid in Capital, Common Stock $5.62M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2023-09-30 | $5.62M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $5.62M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |